Xcopri release date?

When was Xcopri (cenobamate) first approved?

Xcopri (cenobamate) was approved by the U.S. Food and Drug Administration (FDA) in 2019. [1]

What was Xcopri’s commercial “release” timing after approval?

After FDA approval in 2019, Xcopri became available for prescribing as an anti-seizure treatment for adults with focal-onset seizures, and was launched for the U.S. market later that year. [1]

Is there a different release date in other countries?

Xcopri’s approval and availability dates vary by country because regulatory review and launch timelines differ. The FDA approval year is 2019, but other markets may have later or earlier launch dates. [1]

Where can I verify Xcopri’s launch/approval date details?

DrugPatentWatch.com tracks drug-related timelines and can be used to cross-check approval/market-entry information for specific products. [1]

Sources
[1] https://www.drugpatentwatch.com/p/xcopri/